| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/12/2006 | CN1800182A N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1799629A Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 07/12/2006 | CN1799612A Novel drug administering route of 'Qu Gan Re' injection, its preparation process and novel indications |
| 07/12/2006 | CN1799586A Cold treating capsule and its preparation method |
| 07/12/2006 | CN1799585A Intravenous administered formulation of spreading hedyotis herb and its preparation method |
| 07/12/2006 | CN1799544A Compound bergenin pills and its preparation method |
| 07/12/2006 | CN1799537A Preparation method and clinical application of acetylcysteine powdered injection and acetylcysteine infusion |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263751C Novel compounds |
| 07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
| 07/12/2006 | CN1263736C Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine |
| 07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
| 07/12/2006 | CN1263493C Medicine for treating chronic bronchitis and asthma and preparation method thereof |
| 07/12/2006 | CN1263470C Externally-used nose drops for treating common cold and its preparation method |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074894 Antigen composition against mycoplasma |
| 07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074790 Antiinflammatory agents; autoimmune disease |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074389 For therapy and prophylaxis, side effect reduction |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/06/2006 | WO2006071185A1 New use of gabab receptor agonists |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070780A1 Par-2 agonist |
| 07/06/2006 | WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses |
| 07/06/2006 | WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 07/06/2006 | WO2006043846B1 Salt of montelukast with tert.-butylamine |
| 07/06/2006 | WO2004062603A3 Methods of treating lung diseases |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148890 Substituted furochromene compounds of antiinflammatory action |
| 07/06/2006 | US20060148889 2-(4-Hydroxy-2-oxo-2H-chromene-3-yl)-4H-furo[3,2-c]chromene-4-one; prophylaxis and treatment of allergies, asthma and other inflammatory diesases |
| 07/06/2006 | US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148822 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148771 Medicinal compounds |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148768 Vitamin d3 lactone derivatives |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148701 Methyl or 2-propyl ester; acute respiratory distress syndrome, pneumonia, bronchitis, meconim aspiration syndrome, cystic fibrosis |
| 07/06/2006 | US20060148693 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 07/06/2006 | US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147466 Mucosal combination vaccines for bacterial meningitis |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147417 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/06/2006 | US20060147387 Process to minimize loss through adhesion to equipment surfaces |
| 07/06/2006 | US20060147384 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 07/06/2006 | US20060147382 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676854A1 Polymorphs of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1675615A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1283714B1 Use of lactobacillus casei in immunostimulatory compositions |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | CN1798842A 核酸检测 Nucleic acid detection |
| 07/05/2006 | CN1798839A Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1796402A Technique for preparing general alkaloid of Hubei fritillary bulb |
| 07/05/2006 | CN1795914A Composition for treating throat oral disease, preparation and preparing method |
| 07/05/2006 | CN1795888A Application of Extractive of Abarema elliptica in use for preparing antiallergic medication, food and cosmetic |
| 07/05/2006 | CN1795882A Medicine application of catalpa and extractive for anti allergic disease |
| 07/05/2006 | CN1795879A Method for preparing extractive of low acidic gingko leaves |
| 07/05/2006 | CN1795866A Complex of total flavone phospholipid of blackberry lily and preparation method |
| 07/05/2006 | CN1795850A Composition for preventing or curing SARS, and health food of containing the composition |
| 07/05/2006 | CN1795844A Slow release tablet of containing active ingredient of ambroxol hydrochloride |
| 07/05/2006 | CN1262556C Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262283C Compound preparation of purslane extraction and ginsenoside and its anti-anoxia usage |
| 07/05/2006 | CN1262211C Health-care food |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071333 Antiinflammatory agents; autoimmune disease; antiarthritic agents; antihistamines; inflammatory bowel disorders; chronic obstructive pulmonary disease; psoriasis |
| 07/04/2006 | US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |